# A 3-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

> **NCT01220115** · — · COMPLETED · sponsor: **Novartis** · enrollment: 498 (actual)

## Conditions studied

- Sickle Cell Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01220115
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 498 (ACTUAL)
- **Last updated:** 2019-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01220115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01220115, "A 3-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01220115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*